 |
Tetrahydrocannabinol - Administration & dosage
Research News and Information
Definition of 'Tetrahydrocannabinol'A psychoactive compound extracted from the resin of Cannabis sativa (marihuana, hashish). The isomer delta-9-tetrahydrocannabinol (THC) is considered the most active form, producing characteristic mood and perceptual changes associated with this compound. Dronabinol is a synthetic form of delta-9-THC. Common names: Tetrahydrocannabinol; delta(1)-Tetrahydrocannabinol; THC; delta(9)-Tetrahydrocannabinol; delta(9)-THC; Dronabinol; 9-ene-Tetrahydrocannabinol; 9 ene Tetrahydrocannabinol; delta(1)-THC; Tetrahydrocannabinol, (6a-trans)-Isomer; Tetrahydrocannabinol, Trans-Isomer; Tetrahydrocannabinol, Trans Isomer |
Sunday, November 22, 2009
30 Jul 2009 
Although alcohol and nicotine administration studies have demonstrated that manipulating subjects' expectancies regarding drug content affects drug response, research with marijuana has not adequately studied drug expectancy effects. The present ... Read more...
Can recreational doses of THC produce significant dopamine release in the human striatum?
15 Jun 2009 BACKGROUND: Cannabis use in early adolescence may be a risk factor for development of schizophrenia. In animals, Delta9-tetrahydrocannabinol (THC) increases the rate of dopamine neuronal firing and release in the striatum. Thus cannabis use may ... Read more...
12 May 2009 Recent increases in marijuana smoking among the young adult population have been accompanied by the popularization of smoking marijuana as blunts instead of as joints. Blunts consist of marijuana wrapped in tobacco leaves, whereas joints consist of ... Read more...
Latest indexed articles for 'Tetrahydrocannabinol - Administration & dosage'
These are the very latest articles for this heading:
- Effectiveness of a marijuana expectancy manipulation: Piloting the balanced-placebo design for marijuana. 30 Jul 2009
- Can recreational doses of THC produce significant dopamine release in the human striatum? 15 Jun 2009
- Comparison of subjective, pharmacokinetic, and physiological effects of marijuana smoked as joints and blunts. 12 May 2009
- Cannabis coadministration potentiates the effects of "ecstasy" on heart rate and temperature in humans. 11 May 2009
- Synthetic and plant-derived cannabinoid receptor antagonists show hypophagic properties in fasted and non-fasted mice. 30 Mar 2009
- Effect of delta-9-tetrahydrocannabinol on altered antioxidative enzyme defense mechanisms and lipid peroxidation in mice testes. 30 Mar 2009
- (Endo)cannabinoids mediate different Ca2+ entry mechanisms in human bronchial epithelial cells. Mar 2009
- Psychomotor performance in relation to acute oral administration of Delta9-tetrahydrocannabinol and standardized cannabis extract in healthy human subjects. 15 Feb 2009
- Cluster attacks responsive to recreational cannabis and dronabinol. 9 Feb 2009
- Chronic treatment with Delta(9)-tetrahydrocannabinol impairs spatial memory and reduces zif268 expression in the mouse forebrain. 30 Jan 2009
- Emerging strategies for exploiting cannabinoid receptor agonists as medicines. 30 Jan 2009
- Psychopathological and cognitive effects of therapeutic cannabinoids in multiple sclerosis: a double-blind, placebo controlled, crossover study. 30 Dec 2008
- Biomarkers for the effects of cannabis and THC in healthy volunteers. 30 Dec 2008
- Cognitive and psychomotor effects in males after smoking a combination of tobacco and cannabis containing up to 69 mg delta-9-tetrahydrocannabinol (THC). 18 Dec 2008
- The effects of cannabinoids on serum cortisol and prolactin in humans. 14 Dec 2008
- Should we recriminalize cannabis use? The case against.
29 Nov 2008 - Substitution profile of Delta9-tetrahydrocannabinol, triazolam, hydromorphone, and methylphenidate in humans discriminating Delta9-tetrahydrocannabinol. 17 Nov 2008
- Fatty acid amide hydrolase inhibition heightens anandamide signaling without producing reinforcing effects in primates. 21 Sep 2008
- Preliminary evidence of cannabinoid effects on brain-derived neurotrophic factor (BDNF) levels in humans. 19 Sep 2008
- [Delta-9-tetrahydrocannabinol pharmacokinetics] 27 Aug 2008
See a longer list of these articles.
Technical information about 'Tetrahydrocannabinol'
Definition: A psychoactive compound extracted from the resin of Cannabis sativa (marihuana, hashish). The isomer delta-9-tetrahydrocannabinol (THC) is considered the most active form, producing characteristic mood and perceptual changes associated with this compound. Dronabinol is a synthetic form of delta-9-THC.
Chemical name: 6H-Dibenzo(b,d)pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, (6aR-trans)-
Registry Number: 1972-08-3
Descriptor UI: D013759
Alternative terms: Tetrahydrocannabinol; delta(1)-Tetrahydrocannabinol; THC; delta(9)-Tetrahydrocannabinol; delta(9)-THC; Dronabinol; 9-ene-Tetrahydrocannabinol; 9 ene Tetrahydrocannabinol; delta(1)-THC; Tetrahydrocannabinol, (6a-trans)-Isomer; Tetrahydrocannabinol, Trans-Isomer; Tetrahydrocannabinol, Trans Isomer; Tetrahydrocannabinol, (6aS-cis)-Isomer; Tetrahydrocannabinol, Trans-(+-)-Isomer; Marinol; Solvay Brand of Tetrahydrocannabinol; Tetrahydrocannabinol, (6aR-cis)-Isomer;
Allowable Qualifiers: administration & dosage; adverse effects; analogs & derivatives; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists; biosynthesis;
Pharmacological Action: Hallucinogens; Psychotropic Drugs; Analgesics, Non-Narcotic;
Tree Number: D02.455.849.090.810;
History Note: 77(71); was see under CANNABIS 1975-76